Beaufort Securities view on Advanced Oncotherapy “two things observed”
Beaufort Securities view on Advanced Oncotherapy: Yesterday’s agreement with Thales tells investors two things: (i) That the signing of an agreement with such a highly prestigious global operator, that generally